Polypharmacy can predict clinical outcomes among persons with rheumatoid arthritis, according to results of a new study.
The researchers evaluated data of 22,005 patients with RA enrolled in the British Society for...
Polypharmacy can predict clinical outcomes among persons with rheumatoid arthritis, according to results of a new study.
The researchers evaluated data of 22,005 patients with RA enrolled in the British Society for...
The American College of Rheumatology (ACR) and the Arthritis Foundation have issued the first guideline for the treatment of children with juvenile idiopathic arthritis (JIA)–associated uveitis that includes...
The American College of Rheumatology (ACR) and the Arthritis Foundation have issued the first guideline for the treatment of children with juvenile idiopathic arthritis (JIA)–associated uveitis that includes...
Short-term, low-dose prednisolone can improve pain-related symptoms and inflammation caused by hand osteoarthritis (OA), according to a new study presented at the Annual European Congress of Rheumatology. The findings...
Short-term, low-dose prednisolone can improve pain-related symptoms and inflammation caused by hand osteoarthritis (OA), according to a new study presented at the Annual European Congress of Rheumatology. The findings...
Intravenous golimumab remains safe and effective through 1 year for patients with active ankylosing spondylitis (AS), according to a new study.
To evaluate golimumab’s efficacy, the researchers of the GO-ALIVE...
Intravenous golimumab remains safe and effective through 1 year for patients with active ankylosing spondylitis (AS), according to a new study.
To evaluate golimumab’s efficacy, the researchers of the GO-ALIVE...